MoonLake Immunotherapeutics (MLTX)
18.49
+4.15
(+28.94%)
USD |
NASDAQ |
Jan 09, 16:00
19.38
+0.89
(+4.81%)
After-Hours: 20:00
MoonLake Immunotherapeutics EPS Diluted (Quarterly): -1.100 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Baxter International, Inc. | 0.0175 |
| aTyr Pharma, Inc. | -0.265 |
| BeOne Medicines Ltd. | 1.092 |
| AC Immune SA | -0.1964 |
| CRISPR Therapeutics AG | -1.166 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -70.69M |
| Total Expenses (Quarterly) | 69.73M |
| Enterprise Value | 1.008B |
| Earnings Yield | -18.00% |
| Normalized Earnings Yield | -18.00 |